At Thelial Technologies SA we focus on biological barriers. Using our patented platform technology we have discovered a set of candidate compounds. The first product, targeting esophagus health, was launched by Epinutra (www.epinutra.com) in Q4 2020.
In March 2020 we moved to new offices at
Incubadora Universidade de Lisboa